Insights
MedCity unveils thriving future for life sciences in London
09 Oct 2024MedCity has revealed an exciting vision for London as the premier global destination for life science - that brings together world leading research, an exceptional health system, a thriving commercial ecosystem and first class talent.
Did adjective apply to the whole list or just the first item? Court of Appeal gives ruling
25 Sept 2024Sometimes, parties to contracts look back at the wording they used and wish they would have been clearer.
Digital dose: using social media and online platforms to market and sell medicines and medical products
25 Sept 2024Recent attention has focused on the relationship between social media and medical products, as healthcare professionals noted an increase in influencers marketing unlicensed versions of the weight loss drug, semaglutide (branded as Ozempic and Wegovy).
Key Deadlines for the Windsor Framework: what you need to know about medicine regulations
25 Sept 2024Marketing authorisation holders (MAHs) are required to take specific actions regarding their product licenses in Northern Ireland (NI) and Great Britain (GB) by 30 September 2024 to avoid potential regulatory complications.
How's it going for pharma SMEs in the EU?
04 Sept 2024In the EU, there are regulations - lots of them. There's even a specific regulation for micro, small and medium-sized enterprises (SMEs) in the pharma sector. The EU is seeking opinions on support for pharmaceutical SMEs.
£100 million boost to quantum hubs to aid life sciences innovations
04 Sept 2024The UK Government has recently allocated substantial funding of over £100 million to support five new quantum research hubs across the UK.
